30

R&G PharmaStudies Co LtdSHE 301333 Stock Report

Last reporting period 31 Mar, 2023

Updated 19 Sep, 2024

Last price

Market cap $B

0.765

Micro

Exchange

XSHE - Shenzhen Stock Exchange

View Full Company Analysis

Cash flow from operating activities CFO

0.018 B

Last period CFO ,CNY


What is CFO ?

Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.

What is CFO ?

Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.

What is CFO of R&G ?

R&G`s CFO for the period ended 2023-03-31 is 0.018 B CNY

View Full Company Analysis